Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: a promising strategy for treating retinal degenerative diseases
Abstract Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic strategy in regenerative medicine, demonstrating significant potential for clinical applications. Evidence suggests that MSCs not only exhibit multipotent differentiation potential but also exert critical therapeutic effects in retinal degenerative diseases via robust paracrine mechanisms. MSCs protect retinal cells from degenerative damage by modulating inflammation, […]
Therapeutic effect of mesenchymal stem cells and their derived exosomes in diseases
Abstract Mesenchymal stem cells (MSCs) are multipotent stem cells characterized by their robust proliferative capacity, homing ability, differentiation potential, and low immunogenicity in vitro. MSCs can be isolated from a variety of tissues, primarily including but not limited to bone marrow, adipose tissue, umbilical cord, placenta, and dental pulp. Although there have been a large […]
Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges
Aref Yarahmadi Aref Yarahmadi9* 1Kurdistan University of Medical Sciences, Kurdistan, Iran 2Tabriz University of Medical Sciences, Tabriz, Iran 3Department of Medical Laboratory, Faculty of Medicine, Sari Branch, Islamic Azad University, Sari, Iran 4Department of Physical Medicine and Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran 5Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of […]
Immunomodulatory Role of Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review
Abstract The progressive immune-mediated disease known as multiple sclerosis (MS) is characterized by myelin degradation, inflammation, and neurodegeneration. Recent research has examined the potential of mesenchymal stem cell (MSC) therapy for treatment, focusing on its neuroprotective and immunomodulatory properties. This study looked at how MSC transplantation affects cerebrospinal fluid (CSF) biomarkers and the immune system, […]
Stem Cell Treatment For Hair Loss in 2025
Feature | Stem Cell Treatment For Hair Loss 96 SharesLinkedInXFacebookPinterest95Email Stem Cell Treatment For Hair Loss in 2025 March 4, 2025 By Marie Carroll 9 Comments The latest development in stem cell research – stem cell treatment for hair loss – shows great promise for stimulating new hair growth. It addresses the problem of thinning […]
Application of Mesenchymal Stem Cells and Exosome alone or Combination Therapy as a Treatment Strategy for Wound Healing
Abstract The process of wound healing consists of multiple phases, and any disruptions in these phases can lead to the wound becoming chronic and impose heavy financial and psychological costs on the patient and a huge economic burden on the country’s healthcare system. Various treatments such as drugs, matrix and scaffolds, blood products, cell therapy, […]
Adipose-derived mesenchymal stromal/stem cells in type 1 diabetes treatment
Abstract Adipose tissue-derived mesenchymal stromal/stem cells (ADMSCs) represent a novel therapeutic intervention for Type 1 Diabetes (T1D). The attractiveness of ADMSCs is characterized by their immunomodulatory activities, regenerative properties, and relative ease of access. ADMSC therapies in animal models and clinical trials have revealed decreased insulin dependence, increased β cell mass, and improved islet graft […]
China’s NMPA Approves Country’s First MSC-Based Cell Therapy, Ruibosheng
On January 2, 2025, China’s National Medical Products Administration (NMPA) granted conditional approval to Platinum Life Excellence Biotech Co. Ltd.’s amimestrocel injection (hUC-MSC PLEB-001), marking a significant milestone in the country’s medical and biotechnological advancements. The product is being marketing under the brand name Ruibosheng. This approval designates it as China’s first human umbilical cord-derived […]
Heart defects affect 40,000 US babies every year — but cutting edge AI and stem cell tech will save lives and even cure them in the womb
By Jeanette Settembre and Megan Palin Published Nov. 8, 2024, 6:00 a.m. ET 10 Comments Katie Blue-Pugh was just a few hours old when her lips turned blue and panic suddenly set in for her parents and staff in a California maternity ward. Later that day, doctors discovered she had a major heart defect, born […]
JPM25: Bayer moves allogeneic cell therapy into phase 3 Parkinson’s trial
Bayer’s BlueRock Therapeutics is launching a phase 3 trial for Parkinson’s disease, with an expected enrollment of 102 patients. (iStock / Getty Images Plus) Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell therapy in the […]